Share on LinkedInShare on LinkedIn

ARTICLE · 03 NOVEMBER 2013

When narrow patent claims can really work

A CIPO can add value in between blockbuster patents through good practices, by being kept informed of new developments.

New ZealandIntellectual Property

Recent figures from Ireland on the effect of the patent cliff are a timely reminder to CIPOs to look again at their internal practices to ameliorate the possible effect of their companies' own patent cliffs

The effect of the pharmaceutical patent1 cliff is still evident around the world, with the latest fall-out cited in new figures from the Irish Exporters Association. A contraction in the Irish merchandise sector of €2.9 billion is mainly attributed to the loss of pharmaceutical exports and coincides with Pzifer's Viagra– the main ingredients of which are made in Cork – coming off patent.

As anyone in R&D knows, you cannot necessarily force the development of breakthrough compounds such as Lipitor, Viagra or Roundup. But IP2 counsel can put practices in place to lessen the revenue drop which occurs when a major product is out of patent.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from